A murine model of systemic candidiasis was used to assess the virulenc
e of serial Candida albicans strains for which fluconazole MICs sere i
ncreasing. Serial isolates from five patients with 17 episodes of orop
haryngeal candidiasis were evaluated. The MICs for these isolates exhi
bited at least an eightfold progressive increase from susceptible (MIC
< 8 mu g/ml; range, 0.25 to 4 mu g/ml) to resistant (MIC greater than
or equal to 16 mu g/ml; range, 16 to greater than or equal to 128 mu
g/ml). Virulence of the serial isolates from three of five patients sh
owed a more than fivefold progressive decrease in the dose accounting
for 50% mortality and was associated with development of fluconazole r
esistance. Low doses of fluconazole prolonged survival of mice infecte
d with susceptible yeasts but failed to prolong survival following cha
llenge with a resistant strain. In addition, a decreased burden of ren
al infection was noted in mice challenged with two of the three resist
ant strains. This was consistent with reduced virulence. Fluconazole d
id not further decrease the level of infection. In the isolates with a
decrease in virulence, two exhibited overexpression of CDR, which enc
odes an ABC drug efflux pump. In contrast, serial isolates from the re
maining two patients with the development of resistance did not demons
trate a change in virulence and fluconazole remained effective in prol
onging survival, although significantly higher doses of fluconazole we
re required for efficacy, Resistant isolates from both of these patien
ts exhibited overexpression of MDR, This study demonstrates that decre
ased virulence of serial C. albicans isolates is associated with incre
asing fluconazole MICs in some cases but not in others and shows that
these low-virulence strains may not consistently cause infection.